Hirofumi Kawanaka
Overview
Explore the profile of Hirofumi Kawanaka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
131
Citations
910
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoshida D, Sugiyama M, Nakazono K, Oyama T, Hasegawa T, Kai S, et al.
Anticancer Res
. 2023 Jun;
43(7):3225-3233.
PMID: 37351999
Background/aim: This study aimed to evaluate the clinical impact of the level of inferior mesenteric artery (IMA) ligation in patients with advanced low rectal cancer. Patients And Methods: All enrolled...
2.
Hu Q, Oki E, Yamada T, Kashiwada T, Sonoda H, Kataoka M, et al.
Cancer Med
. 2023 Jun;
12(15):16649-16660.
PMID: 37325934
Background: We aimed to clarify the genomic characteristics of HER2-positive and negative gastric cancer cases that potentially affect tumor progression and treatment response in a prospective trial. Methods: We collected...
3.
Kobayshi K, Suyama K, Katsuya H, Izawa N, Uenosono Y, Hu Q, et al.
Eur J Cancer
. 2022 Mar;
166:279-286.
PMID: 35349925
Background: The mainstream first-line chemotherapy for advanced/recurrent gastric cancer (ARGC) is combination therapy including platinum-based agents. With the progressive aging of the society, the incidence of gastric cancer in elderly...
4.
Ohta M, Murashima N, Ohyama T, Yoshida T, Hirota S, Kawanaka H, et al.
DEN Open
. 2022 Mar;
2(1):e74.
PMID: 35310701
Objectives: The diverse treatments available for portal hypertension require specialized knowledge of hemodynamics and include endoscopic treatments, interventional radiology (IVR), and surgery. The Japan Society for Portal Hypertension has developed...
5.
Miyoshi T, Miyashita H, Matsuo N, Odawara M, Hori M, Hiraki Y, et al.
Biol Pharm Bull
. 2021 Oct;
44(10):1413-1418.
PMID: 34602550
The triplet antiemetic regimen is administered to prevent chemotherapy-induced nausea and vomiting (CINV) after moderately emetogenic chemotherapy (MEC). However, the superiority of palonosetron over first-generation 5-hydroxytryptamine-3 receptor antagonists in triplet...
6.
Guo J, Akahoshi T, Mizuta Y, Murata M, Narahara S, Kawano T, et al.
Liver Transpl
. 2020 Dec;
27(6):840-853.
PMID: 33259137
Hepatic ischemia/reperfusion injury (IRI) is a major complication of liver surgery and transplantation, especially in patients with nonalcoholic steatohepatitis (NASH). The mechanism of NASH susceptibility to IRI has not been...
7.
Oki E, Makiyama A, Miyamoto Y, Kotaka M, Kawanaka H, Miwa K, et al.
Cancer Med
. 2020 Nov;
10(2):454-461.
PMID: 33249761
Background: A previous Phase I/II study demonstrated that TAS-102 (trifluridine/tipiracil [FTD/TPI]) plus bevacizumab (Bev) has encouraging efficacy and controllable safety for patients with previously treated metastatic colorectal cancer. Therefore, we...
8.
Kashiwada T, Shinozaki K, Ueno S, Kawanaka H, Uno F, Okita Y, et al.
Int J Clin Oncol
. 2020 Oct;
26(2):345-354.
PMID: 33085058
Background: In a randomized pivotal global phase III study, S-1 and oxaliplatin 100 mg/m (SOX100) combination chemotherapy was as effective as S-1 and cisplatin for advanced gastric cancer (AGC) and...
9.
Uehara H, Kawanaka H, Nakanoko T, Sugiyama M, Ota M, Mano Y, et al.
Surg Case Rep
. 2020 Sep;
6(1):236.
PMID: 32990797
Background: Ectopic variceal bleeding is a rare but life-threatening complication of portal hypertension (PH). Oxaliplatin-based chemotherapy for colorectal cancer (CRC) is associated with sinusoidal obstruction syndrome of the liver, which...
10.
Harimoto N, Araki K, Muranushi R, Hoshino K, Hagiwara K, Ishii N, et al.
Surg Case Rep
. 2020 Aug;
6(1):190.
PMID: 32737609
Background: Liver cirrhosis occurs in approximately 80-90% of patients with hepatocellular carcinoma (HCC), and hepatic resection may be dangerous because of well-documented liver cirrhosis, which may be accompanied by portal...